Luspatercept in β‐thalassemia: Who and when. Strengths and weaknesses points of a real‐world evidence
Year: 2024
Type: article
Abstract: adverse events,
Source: eJHaem
DOI: 10.1002/jha2.1032
Institutions: ASL Roma, St. Eugenio Hospital
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,600
OpenAlex ID: W4404045069
